| Ms Rebekah Ashleigh Hodge, MD | |
|
222 Medical Circle, Morehead, KY 40351-1179 | |
| (606) 783-6500 | |
| Not Available |
| Full Name | Ms Rebekah Ashleigh Hodge |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 222 Medical Circle, Morehead, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720511736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 55596 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rebekah Ashleigh Hodge, MD 7619 W Jefferson Blvd, Fort Wayne, IN 46804-4133 Ph: (866) 413-9534 | Ms Rebekah Ashleigh Hodge, MD 222 Medical Circle, Morehead, KY 40351-1179 Ph: (606) 783-6500 |
News Archive
Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue.
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration (AMD). Treating diabetic macular edema (DME) with ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone, according to the Diabetic Retinopathy Clinical Research (DRCR) Network study published today in Ophthalmology online, the journal of the American Academy of Ophthalmology (Academy). DME is the main cause of vision loss in people with diabetes mellitus.
Universal Capital Management, Inc. (OTCBB: UCMT), a Wilmington, Delaware business development company that provides management and strategic growth resources to emerging growth companies, is pleased to announce the addition of Innovation Industries to its portfolio.
All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.
› Verified 1 days ago
Alyssa Davis, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 Academic-athletic Center, Morehead, KY 40351 Phone: 606-783-2089 | |
Dr. Benjamin B Mattingly, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 413-813-5330 | |
Caren Daniels, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 260-407-8000 Fax: 260-407-8004 | |
Philip Charles Overall, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 222 Medical Circle, Morehead, KY 40351 Phone: 859-582-9528 | |
Dr. Adam Wesley Scrogham, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Mark E Bailey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 Fax: 260-407-8004 | |
Kimberly Williams, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6608 Fax: 606-783-6503 |